# GRAVITY Co., Ltd.: financial statements, quarterly

GRVY · Nasdaq · CIK 1313310 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/grvy.md) · [Financials](/companies/grvy/financials.md) · [Filings](/companies/grvy/filings.md) · [Insiders](/companies/grvy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/grvy/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2013 (2013-12-31) | FY2014 (2014-12-31) | FY2015 (2015-12-31) | FY2016 (2016-12-31) | FY2017 (2017-12-30) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0001047469-15-003935.md) | [0.0](/filings/0001193125-16-547162.md) | [0.0](/filings/0001193125-17-145523.md) | [0.0](/filings/0001193125-17-145523.md) | [39.1](/filings/0001564590-19-013202.md) | [86.1](/filings/0001628280-22-010914.md) | [79.4](/filings/0001628280-23-013345.md) | [111](/filings/0001628280-24-048028.md) | [99.1](/filings/0001628280-25-019782.md) | [170](/filings/0001628280-25-019782.md) | [184](/filings/0001628280-25-019782.md) | [229](/filings/0001628280-25-019782.md) |
| Current assets | $bn | [0.1](/filings/0001047469-14-004408.md) | [0.0](/filings/0001047469-15-003935.md) | [0.0](/filings/0001193125-16-547162.md) | [0.0](/filings/0001193125-17-145523.md) | [109](/filings/0001564590-19-013202.md) | [160](/filings/0001564590-20-019403.md) | [156](/filings/0001564590-21-021574.md) | [247](/filings/0001628280-22-010914.md) | [306](/filings/0001628280-23-013345.md) | [422](/filings/0001628280-24-048028.md) | [547](/filings/0001628280-25-019782.md) | [654](/filings/0001628280-25-019782.md) |
| Total assets | $bn | [0.1](/filings/0001047469-14-004408.md) | [0.1](/filings/0001047469-15-003935.md) | [0.0](/filings/0001193125-16-547162.md) | [0.0](/filings/0001193125-17-145523.md) | [116](/filings/0001564590-19-013202.md) | [173](/filings/0001564590-20-019403.md) | [175](/filings/0001564590-21-021574.md) | [265](/filings/0001628280-22-010914.md) | [328](/filings/0001628280-23-013345.md) | [444](/filings/0001628280-24-048028.md) | [578](/filings/0001628280-25-019782.md) | [686](/filings/0001628280-25-019782.md) |
| Current liabilities | $bn | [0.0](/filings/0001047469-14-004408.md) | [0.0](/filings/0001047469-15-003935.md) | [0.0](/filings/0001193125-16-547162.md) | [0.0](/filings/0001193125-17-145523.md) | [64.7](/filings/0001564590-19-013202.md) | [93.5](/filings/0001564590-20-019403.md) | [55.8](/filings/0001564590-21-021574.md) | [82.7](/filings/0001628280-22-010914.md) | [74.0](/filings/0001628280-23-013345.md) | [106](/filings/0001628280-24-048028.md) | [106](/filings/0001628280-25-019782.md) | [109](/filings/0001628280-25-019782.md) |
| Total liabilities | $bn | [0.0](/filings/0001047469-14-004408.md) | [0.0](/filings/0001047469-15-003935.md) | [0.0](/filings/0001193125-16-547162.md) | [0.0](/filings/0001193125-17-145523.md) | [71.9](/filings/0001564590-19-013202.md) | [97.6](/filings/0001564590-20-019403.md) | [59.7](/filings/0001564590-21-021574.md) | [88.0](/filings/0001628280-22-010914.md) | [80.7](/filings/0001628280-23-013345.md) | [114](/filings/0001628280-24-048028.md) | [114](/filings/0001628280-25-019782.md) | [118](/filings/0001628280-25-019782.md) |
| Shareholders' equity | $bn | [0.1](/filings/0001047469-14-004408.md) | [0.0](/filings/0001047469-15-003935.md) | [0.0](/filings/0001193125-16-547162.md) | [0.0](/filings/0001193125-17-145523.md) | [44.6](/filings/0001564590-19-013202.md) | [76.2](/filings/0001564590-20-019403.md) | [116](/filings/0001564590-21-021574.md) | [177](/filings/0001628280-22-010914.md) | [246](/filings/0001628280-23-013345.md) | [330](/filings/0001628280-24-048028.md) | [463](/filings/0001628280-25-019782.md) | [568](/filings/0001628280-25-019782.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, ifrs-full:CashAndCashEquivalents
- Current assets: us-gaap:AssetsCurrent, ifrs-full:CurrentAssets
- Total assets: us-gaap:Assets, ifrs-full:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent, ifrs-full:CurrentLiabilities
- Total liabilities: us-gaap:Liabilities, ifrs-full:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 6,948,900 at 2025-12-31, from the cover of the [20-F filed 2026-04-24](/filings/0001628280-26-026985.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.